2025
SJR Q1
JCR Q2 · 3
12 matched articles
SCIE
Journal detail
Molecular Pharmacology
- Publisher
- Elsevier Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0026895X15210111
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,15
- Quartile Q1
- H-Index 218
- Cites/doc 2,93
- Docs (3y) 191
- Cites (3y) 589
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3
- 5Y JIF 3,3
- JCI 0,79
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Molecular Medicine Q2
- Pharmacology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,15 | 3 | 3,3 | 0,79 | Q2 | 218 |
| 2024 | Q1 | Q2 | 1,052 | 3 | 2,9 | 0,77 | Q2 | 215 |
| 2023 | Q1 | Q2 | 1,038 | 3,2 | 3,5 | 0,87 | Q2 | 215 |
| 2022 | Q1 | Q2 | 1,061 | 3,6 | 4 | 0,94 | Q2 | 215 |
| 2021 | Q1 | Q2 | 1,269 | 4,1 | 4,8 | 1,17 | Q1 | 215 |
| 2020 | Q1 | Q2 | 1,469 | 4,4 | 4,6 | 1,21 | Q1 | 215 |
| 2019 | Q1 | Q2 | 1,517 | 3,7 | 3,9 | 1,36 | Q1 | 215 |
| 2018 | — | Q1 | — | 3,9 | 3,8 | 1,37 | Q1 | — |
| 2017 | Q1 | Q1 | 2,076 | 4 | 3,9 | 1,51 | Q1 | 215 |
| 2016 | Q1 | Q1 | 2,199 | 3,9 | 3,9 | — | — | 215 |
| 2015 | Q1 | Q1 | 2,037 | 3,9 | 4 | — | — | 215 |
| 2014 | Q1 | Q1 | 2,298 | 4,1 | 4,4 | — | — | 215 |
| 2013 | Q1 | Q1 | 2,516 | 4,1 | 4,6 | — | — | 215 |
| 2012 | Q1 | Q1 | 2,471 | 4,4 | 4,5 | — | — | 215 |
| 2011 | Q1 | Q1 | 2,518 | 4,9 | 4,6 | — | — | 215 |
| 2010 | Q1 | Q1 | 2,463 | 4,7 | 4,7 | — | — | 215 |
| 2009 | — | Q1 | — | 4,5 | 4,7 | — | — | — |
| 2008 | — | Q1 | — | 4,7 | 4,9 | — | — | — |
| 2007 | — | Q1 | — | 4,1 | 4,5 | — | — | — |
| 2006 | — | Q1 | — | 4,5 | — | — | — | — |
| 2005 | — | Q1 | — | 4,6 | — | — | — | — |
| 2004 | — | Q1 | — | 5,1 | — | — | — | — |
| 2003 | — | Q1 | — | 5,7 | — | — | — | — |
| 2002 | — | Q1 | — | 5,5 | — | — | — | — |
| 2001 | — | Q1 | — | 5,3 | — | — | — | — |
| 2000 | — | Q1 | — | 5,7 | — | — | — | — |
| 1999 | — | Q1 | — | 5,5 | — | — | — | — |
| 1998 | — | Q1 | — | 5,4 | — | — | — | — |
| 1997 | — | Q1 | — | 4,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 169/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 138/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 124/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 114/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 112/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 85/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 75/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 58/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 43/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 46/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 46/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 38/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 34/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 35/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 22/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 23/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 28/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 22/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 29/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 26/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 22/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 16/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 12/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 9/188 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 52/308 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 8/186 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 40/310 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 5/181 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 34/295 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 7/175 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 33/295 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 6/178 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 38/253 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 9/157 |